Abstract:Objective: To evaluate the predictive power of the high-sensitivity C-reactive protein (hs-CRP) to albumin (Alb) ratio for cardiovascular events in patients receiving maintenance hemodialysis (MHD) for end-stage renal disease (ESRD). Methods: This retrospective study enrolled 202 ESRD patients undergoing MHD at Bobai County People's Hospital from November 2020 to November 2022, with follow-up extending to November 2023. Patients were divided into two groups based on the occurrence of cardiovascular events during follow-up: the occurrence group (n = 92) and the non-occurrence group (n = 110). Clinical data were compared between these groups. Independent risk factors for cardiovascular events post-MHD were identified using a multivariate logistic regression model. The hs-CRP/Alb ratio's predictive utility was assessed through receiver operating characteristic (ROC) curve analysis, establishing an optimal cutoff value. A decision tree prediction model was developed to further delineate the probability of cardiovascular events. Results: The occurrence group was older and had a longer duration of dialysis compared to the non-occurrence group (P < 0.05). They also showed a higher prevalence of diabetic and hypertensive nephropathy and a higher proportion of smokers (all P < 0.05). Notably lower levels of hemoglobin (HGB), triglycerides, total cholesterol, low-density lipoprotein, albumin (Alb), and calcium were detected (all P < 0.05), whereas β2-microglobulin (β2-mg), hs-CRP, phosphorus, and the hs-CRP/Alb ratio were markedly increased (all P < 0.05). Multivariate analysis revealed diabetic nephropathy or hypertensive nephropathy, a high hs-CRP/Alb ratio, and elevated phosphorus levels as risk factors for cardiovascular events, while high hemoglobin levels were protective (P < 0.05). The ROC analysis indicated the hs-CRP/Alb ratio (AUC = 0.884) outperformed other predictors with an optimal cutoff at 0.111. Patients with a hs-CRP/Alb ratio ≥ 0.111 were found to have a 29-fold increased risk of cardiovascular events (95% CI: 11.304-74.842). Conclusion: The hs-CRP/Alb ratio is a significant predictive biomarker for cardiovascular events in ESRD patients undergoing MHD. An elevated hs-CRP/Alb ratio is associated with an increased risk of cardiovascular events, underscoring its utility in this patient population.

Relationship of High-sensitivity C-reactive protein levels and chronic renal failure and dialysis patients

Serum High Sensitive C-reactive Protein Level Correlates with Cardiac Structure and Function in Patients Maintained on Hemodialysis

A Study on the Relationship between Serum hs-CRP Level and the Risk of Cardiovascular Complications in Patients with Chronic Renal Disease

Change of serum high-sensitivity C-reactive protein in patients with chronic kidney disease

Relationship Between Serum High Sensitive C-reactive Protein and Vascular Dysfunction in Hemodialysis Patients

The Relationship Between High Sensitive C-reactive Protein and Prealbumin among Maintenance Hemodialysis Patients

Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure

Serum C-reactive protein level correlates with cardiovascular morbidity and stability in maintenance hemodialysis patients

Precedent Fluctuation of Serum hs-CRP to Albumin Ratios and Mortality Risk of Clinically Stable Hemodialysis Patients

The Relationship Between C?reaction Protein and Prognosis in Maintenance Hemodialysis Patients

Relationship between serum C-reactive protein levels and serum nutrition parameters, blood lipids or heart function in patients undergoing maintenance hemodialysis

Association of Baseline, Longitudinal Serum High-Sensitive C-reactive Protein and Its Change with Mortality in Peritoneal Dialysis Patients

The Clinical Significance and Changes of CysC, Hey and PTH Levels of Patients with Chronic Renal Failure before and after Treatment

Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.

Change of C-Reactive Protein in Patients with Chronic Renal Insufficiency and the Clinical Significance

Prognostic significance of the hs-CRP/Alb ratio for cardiovascular events in patients with end-stage renal disease undergoing maintenance hemodialysis

Assessment of serum cardiac troponin T and C-reactive protein in predicting hemodialysis outcome

The Association Between High Sensitivity C-reactive Protein in Patients with Essential Hypertension

The Clinical Value of the Serum High-sensitivity C-reactive Protein and Cystatin C Level in Coronary Heart Disease Patients

Prognostic Value of High-Sensitivity C-reactive Protein in Patients with Chronic Heart Failure.